Assembly Biosciences (ASMB) Research & Development (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Research & Development of $14.9 million for Q1 2026, little changed year-over-year from $14.9 million in Q1 2025, and down 13.62% quarter-over-quarter from $17.2 million in Q4 2025.
Assembly Biosciences (ASMB) Research & Development (2010 - 2026) Analysis & Trends
Assembly Biosciences' Research & Development history runs 17 years deep, the most recent figure standing at $14.9 million for Q1 2026.
- In Q1 2026, Research & Development changed 0.33% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $64.9 million (up 10.11% YoY), while the FY2025 annual figure was $64.8 million, up 15.88% from the prior year.
- Research & Development for Q1 2026 stood at $14.9 million, down from $17.2 million in the prior quarter.
- The five-year high for Research & Development was $18.1 million in Q3 2022, with the low at $10.8 million in Q3 2023.
- The 5-year median for Research & Development is $14.9 million (2026), against an average of $15.0 million.
- The sharpest annual moves came in 2023 and 2024: Research & Development plunged 40.3% in 2023, then advanced 29.83% in 2024.
- Assembly Biosciences' Research & Development stood at $16.9 million in 2022, then tumbled by 34.69% to $11.0 million in 2023, then advanced by 29.75% to $14.3 million in 2024, then advanced by 20.8% to $17.2 million in 2025, then declined by 13.62% to $14.9 million in 2026.
- Business Quant data shows ASMB's Research & Development at $14.9 million in Q1 2026, $17.2 million in Q4 2025, and $16.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 14.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.92 Mn |
| Mar 31, 2026 | 14.90 Mn |
| Dec 31, 2025 | 17.25 Mn |
| Sep 30, 2025 | 16.59 Mn |
| Jun 30, 2025 | 16.13 Mn |
| Mar 31, 2025 | 14.85 Mn |
| Dec 31, 2024 | 14.28 Mn |
| Sep 30, 2024 | 13.52 Mn |
| Jun 30, 2024 | 16.26 Mn |
| Mar 31, 2024 | 11.88 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 10.82 Mn |
| Jun 30, 2023 | 12.52 Mn |
| Mar 31, 2023 | 14.55 Mn |
| Dec 31, 2022 | 16.85 Mn |
| Sep 30, 2022 | 18.13 Mn |
| Jun 30, 2022 | 17.79 Mn |
| Mar 31, 2022 | 17.21 Mn |
| Dec 31, 2021 | 14.75 Mn |
| Sep 30, 2021 | 18.47 Mn |